Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
14 results
  1. Non-pharmacological interventions for people living with dementia - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536485
    ... souvenaid versus placebo. 13.2.4.9.4. Huperzine A Very low- to low-quality evidence from ... with mild to moderate Alzheimer’s disease offered Huperzine A versus placebo or no intervention. Moderate-quality ...
  2. Meta-analysis & network meta-analysis results - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536506
    ... Souvenaid Cognition (post-intervention) ADCS-ADL (post-intervention) Huperzine A MMSE (post-intervention) ADL (post-intervention) BPSD ( ...
  3. References - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536508
    ... JD, Sou ML. Double-blind controlled treatment of huperzine-A and placebo in 28 patients with Alzheimer ... Disease Cooperative Study. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. ...
  4. Excluded References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556577
    ... Ding JM, Zhong P, et al. Impacts of huperzine A on the level of Fas, Apo2.7 ... al. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: ...
  5. Excluded studies - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536486
    ... Li WN, Yu HY (2011) The efficacy of Huperzine A in treating mild to moderate Data not ... Shi W, Chen XH (2013) Clinical study of huperzine A on patients with mild and moderate Alzheimer ...
  6. Key Question 4: Supplements Versus Placebo for Cognition, Function, and Quality of Life - Diagnosis and Treatment of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556562
    ... efficacy or harms of Prevagen (apoaequorin), phosphotidylserine or Huperzine. Baseline Study Characteristics Eight publications reporting eight trials ...
  7. Introduction - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK556567
    ... interest (e.g., cannabinoids, ginseng, omega 3, gingko, huperzine A), a new comprehensive systematic review examining the ...
  8. Discussion - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK556543
    ... We found no eligible studies for Prevagen (apoaequorin), huperzine or phosphatidylserine. Our findings are mostly consistent with ...
  9. Excluded References - Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical ... 
    https://www.ncbi.nlm.nih.gov/books/NBK442416
    ... Liang XM, Juan W, et al. Treatment with Huperzine A improves cognition in vascular dementia patients. Cell ...